|
MechanismLp-PLA2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismGABRA5 negative allosteric modulator |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai SIMRD Biotechnology Co.,Ltd
0 Patents (Medical) associated with Shanghai SIMRD Biotechnology Co.,Ltd
100 Deals associated with Shanghai SIMRD Biotechnology Co.,Ltd
100 Translational Medicine associated with Shanghai SIMRD Biotechnology Co.,Ltd